Wave Life Sciences logo

Wave Life Sciences

WVE | NASDAQ
Chart Builder DCF Calculator
$2.87
-$0.26 (-8.31%)
At close: Nov 16, 2026, 4:00 PM ET
$2.87
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:31 PM ET
-8.31%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
45.6
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #378/1021 (Top 37%)

Key Statistics

Market Data

Market Cap $566.05M
1D Range
2.86 3.15
52W Range
2.85 21.31

Valuation (TTM)

PE -2.68
PB 1.41
EV/EBITDA -0.87

Valuation (NTM)

Forward PE N/A
Forward PEG 0.41
Price Target $13.00
Loading financial charts...

Profile

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The co...

Sector Healthcare
Industry Biotechnology
Employees 317
IPO Date Nov 11, 2015
Fiscal Year January - December

Latest News

Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover

3 months ago · 247wallst.com

Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover
Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript

3 months ago · seekingalpha.com

Wave Life Sciences Ltd. (WVE) Presents at Bank of America SMID Cap Virtual Conference Transcript
Wave Life Sciences Announces Completion of Redomiciliation to Delaware

3 months ago · globenewswire.com

Wave Life Sciences Announces Completion of Redomiciliation to Delaware
Wave Life Sciences to Present at Upcoming Investor Conferences

3 months ago · globenewswire.com

Wave Life Sciences to Present at Upcoming Investor Conferences
Wave Life Sciences Ltd. (WVE) Q2 2026 Earnings Call Transcript

4 months ago · seekingalpha.com

Wave Life Sciences Ltd. (WVE) Q2 2026 Earnings Call Transcript
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates

4 months ago · zacks.com

Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates
Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update

4 months ago · globenewswire.com

Wave Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026

4 months ago · globenewswire.com

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?

4 months ago · zacks.com

Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock?
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

4 months ago · globenewswire.com

Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation

Earnings

Latest Earnings
Oct 27, 2026
EPS
-$0.3
Beat +8.83%
REV
$13.16M
Beat +191.60%
Next Earnings
Feb 25, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
14
Consensus
Buy
Price Target
$13.00
Upside
+352.96%
Buy (13)
Hold (1)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.